FDA identifies risks to consumers from copycat eye drops sold on marketplaces like Walmart.com. Learn about DEF’s history of concerns with these products and how you can stay safe.

The manufacturer of Regener-Eyes underwent an FDA drug facility inspection for the first time this year. FDA’s report includes extensive citations for violations, including releasing products for commercial distribution despite failed tests.

Dr. Brown’s commentary on a Warning Letter sent by the FDA to K.C. Pharmaceuticals, a large manufacturer of private-label eye drops sold in the US.

Six months, seven manufacturers, eleven products: It’s been an unprecedented year for eye drop recalls and FDA warnings.